Bridgeway Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $865K | Hold |
|
|||||
|
2022
Q3 | $993K | Hold |
|
|||||
|
2022
Q2 | $624K | Buy |
|
|||||
|
2022
Q1 | $314K | Sell |
|
|||||
|
2021
Q4 | $467K | Hold |
|
|||||
|
2021
Q3 | $485K | Buy |
|
|||||
|
2021
Q2 | $477K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $510K | Sell |
|
|||||
|
2019
Q4 | $763K | Sell |
|
|||||
|
2019
Q3 | $853K | Hold |
|
|||||
|
2019
Q2 | $1.74M | Sell |
|
|||||
|
2019
Q1 | $2.36M | Sell |
|
|||||
|
2018
Q4 | $2.71M | Hold |
|
|||||
|
2018
Q3 | $3.21M | Hold |
|
|||||
|
2018
Q2 | $3.64M | Buy |
|
|||||
|
2018
Q1 | $3.78M | Sell |
|
|||||
|
2017
Q4 | $4.32M | Buy |
|
|||||
|
2017
Q3 | $621K | Hold |
|
|||||
|
2017
Q2 | $587K | Sell |
|
|||||
|
2017
Q1 | $1.2M | Buy |
|
|||||
|
2016
Q4 | $290K | Hold |
|
|||||
|
2016
Q3 | $285K | Hold |
|
|||||
|
2016
Q2 | $317K | Sell |
|
|||||
|
2016
Q1 | $594K | Sell |
|
|||||
|
2015
Q4 | $829K | Buy |
|
|||||
|
2015
Q3 | $817K | Hold |
|
|||||
|
2015
Q2 | $648K | Hold |
|
|||||
|
2015
Q1 | $659K | Hold |
|
|||||
|
2014
Q4 | $579K | Buy |
|
|||||
|
2014
Q3 | $170K | Hold |
|
|||||
|
2014
Q2 | $136K | Buy |
|